BioCentury | Mar 17, 2011
Distillery Therapeutics

Indication: Various

...compound and testing it in preclinical models of inflammation and CML. Cornerstone Therapeutics Inc. markets Zyflo CR...
BioCentury | Jun 22, 2009
Clinical News

Singulair montelukast regulatory update

...Singulair montelukast from Merck, Accolate zafirlukast from AstraZeneca plc (LSE:AZN; NYSE:AZN, London, U.K.) and Zyflo/ Zyflo CR...
...events (see BioCentury, Jan. 19). Singulair and Accolate are leukotriene receptor antagonists, while Zyflo and Zyflo CR...
BioCentury | Jun 22, 2009
Clinical News

Zyflo CR zileuton CR regulatory update

...Inc. (NYSE:MRK, Whitehouse Station, N.J.), Accolate zafirlukast from AstraZeneca plc (LSE:AZN; NYSE:AZN, London, U.K.) and Zyflo/Zyflo CR...
...Zyflo and Zyflo CR are leukotriene synthesis inhibitors. Cornerstone Therapeutics Inc. (NASDAQ:CRTX), Cary, N.C. Product: Zyflo CR zileuton CR...
BioCentury | Jun 22, 2009
Clinical News

Zyflo zileuton IR regulatory update

...NYSE:MRK, Whitehouse Station, N.J.), Accolate zafirlukast from AstraZeneca plc (LSE:AZN; NYSE:AZN, London, U.K.) and Zyflo/ Zyflo CR...
...events (see BioCentury, Jan. 19). Singulair and Accolate are leukotriene receptor antagonists, while Zyflo and Zyflo CR...
BioCentury | Jun 22, 2009
Clinical News

Accolate zafirlukast regulatory update

...from Merck & Co. Inc. (NYSE:MRK, Whitehouse Station, N.J.), Accolate zafirlukast from AstraZeneca and Zyflo/ Zyflo CR...
...events (see BioCentury, Jan. 19). Singulair and Accolate are leukotriene receptor antagonists, while Zyflo and Zyflo CR...
BioCentury | Jun 18, 2009
Distillery Therapeutics

Indication: Cancer

...times compared with placebo or Gleevec imatinib. Next steps include testing Zyflo CR in cancer patients. Zyflo CR...
BioCentury | May 18, 2009
Finance

Ebb & Flow

...The completion of the Critical Therapeutics deal last Oct. 31 added Zyflo immediate-release zileuton and Zyflo CR...
BioCentury | May 11, 2009
Company News

Chiesi, Cornerstone Therapeutics sales and marketing update

...in the U.S. Cornerstone said the deal will broaden its respiratory business, which already includes Zyflo CR...
BioCentury | Jan 19, 2009
Clinical News

Singulair montelukast regulatory update

...in patients receiving Singulair, Accolate zafirlukast from AstraZeneca plc (LSE:AZN; NYSE:AZN, London, U.K.), or Zyflo/ Zyflo CR...
BioCentury | Jan 12, 2009
Finance

Post-launch report

...PKU) U.S. $31.6 Cornerstone (NASDAQ:CRTX) Zyflo CR zileuton Prevent and treat asthma U.S. $13.2 (Zyflo & Zyflo CR...
Items per page:
1 - 10 of 50